TABUTEAU HERRIOT Insider Trades

Insider Trading History

Track insider trading activity for TABUTEAU HERRIOT. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $13.5M 56,895 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12M 49,666 shares
$240.66
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $11.8M 49,664 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.9M 49,666 shares
$240.25
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.72M 7,229 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.9M 49,666 shares
$240.25
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $13.5M 56,899 shares
Last Trade
Jun 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2M 49,670 shares
$245.64
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $23.6M 99,330 shares
Last Trade
Jun 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12M 49,670 shares
$241.01
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.72M 7,229 shares
Last Trade
Jun 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$12M 49,670 shares
$241.01
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $5.72M 24,081 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.41M 24,081 shares
$182.97
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $13M 54,623 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.91M 54,623 shares
$163.19
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.02M 32,410 shares
$185.60
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.72M 7,229 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.02M 32,410 shares
$185.60
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $9.42M 39,639 shares
Last Trade
Feb 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.02M 32,410 shares
$185.88
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $9.14M 38,490 shares
Last Trade
Jan 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34M 31,261 shares
$170.69
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.72M 7,229 shares
Last Trade
Jan 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.33M 31,261 shares
$170.38
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $7.7M 32,410 shares
Last Trade
Jan 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.33M 31,261 shares
$170.38
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $8.71M 36,679 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.06M 29,450 shares
$171.88
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.72M 7,229 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.08M 29,450 shares
$172.33
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $15.1M 63,671 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.08M 29,450 shares
$172.33
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $22.1M 93,121 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.5M 78,703 shares
$171.28
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $1.72M 7,229 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.5M 78,703 shares
$171.28
$237.53
Axsome Therapeutics
Axsome Therapeutics AXSM
10% owner, Chief Executive Officer
Holding Value $20.4M 85,932 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.5M 78,703 shares
$171.49
$237.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up